Published in J Natl Cancer Inst on October 05, 2005
Screening for breast cancer: an update for the U.S. Preventive Services Task Force. Ann Intern Med (2009) 11.96
Annual Report to the Nation on the Status of Cancer, 1975-2009, featuring the burden and trends in human papillomavirus(HPV)-associated cancers and HPV vaccination coverage levels. J Natl Cancer Inst (2013) 8.75
Annual report to the nation on the status of cancer, 1975-2005, featuring trends in lung cancer, tobacco use, and tobacco control. J Natl Cancer Inst (2008) 8.14
Racial disparities in cancer survival among randomized clinical trials patients of the Southwest Oncology Group. J Natl Cancer Inst (2009) 5.62
Annual report to the nation on the status of cancer, 1975-2007, featuring tumors of the brain and other nervous system. J Natl Cancer Inst (2011) 5.09
Estrogen receptors and human disease. J Clin Invest (2006) 4.91
The present and future burden of urinary bladder cancer in the world. World J Urol (2009) 4.56
Annual Report to the Nation on the status of cancer, 1975-2008, featuring cancers associated with excess weight and lack of sufficient physical activity. Cancer (2012) 3.55
Studies on anticancer activities of antimicrobial peptides. Biochim Biophys Acta (2007) 3.24
Annual Report to the Nation on the Status of Cancer, 1975-2012, featuring the increasing incidence of liver cancer. Cancer (2016) 2.91
Annual Report to the Nation on the Status of Cancer, 1975-2011, Featuring Incidence of Breast Cancer Subtypes by Race/Ethnicity, Poverty, and State. J Natl Cancer Inst (2015) 2.81
Metformin inhibits cell proliferation, migration and invasion by attenuating CSC function mediated by deregulating miRNAs in pancreatic cancer cells. Cancer Prev Res (Phila) (2011) 2.77
Surgeon recommendations and receipt of mastectomy for treatment of breast cancer. JAMA (2009) 2.64
Breast cancer epidemiology in blacks and whites: disparities in incidence, mortality, survival rates and histology. J Natl Med Assoc (2008) 2.46
Notch-1 induces epithelial-mesenchymal transition consistent with cancer stem cell phenotype in pancreatic cancer cells. Cancer Lett (2011) 2.24
Productivity costs of cancer mortality in the United States: 2000-2020. J Natl Cancer Inst (2008) 2.23
Prevalence of off-label use and spending in 2010 among patent-protected chemotherapies in a population-based cohort of medical oncologists. J Clin Oncol (2013) 2.20
The influence of race, ethnicity, and individual socioeconomic factors on breast cancer stage at diagnosis. Am J Public Health (2006) 2.20
Gene expression signatures of morphologically normal breast tissue identify basal-like tumors. Breast Cancer Res (2006) 2.12
A tracking and feedback registry to reduce racial disparities in breast cancer care. J Natl Cancer Inst (2008) 1.99
Declining death rates reflect progress against cancer. PLoS One (2010) 1.91
Anthropometric measures, body mass index, and pancreatic cancer: a pooled analysis from the Pancreatic Cancer Cohort Consortium (PanScan). Arch Intern Med (2010) 1.88
Racial differences in gene-specific DNA methylation levels are present at birth. Birth Defects Res A Clin Mol Teratol (2011) 1.88
Cigarette smoking and pancreatic cancer: a pooled analysis from the pancreatic cancer cohort consortium. Am J Epidemiol (2009) 1.87
Curcumin analogue CDF inhibits pancreatic tumor growth by switching on suppressor microRNAs and attenuating EZH2 expression. Cancer Res (2011) 1.80
Epidemiology of lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest (2013) 1.77
Protein microarray signature of autoantibody biomarkers for the early detection of breast cancer. J Proteome Res (2010) 1.75
Evaluation of Patient Navigation in a Community Radiation Oncology Center Involved in Disparities Studies: A Time-to-Completion-of-Treatment Study. J Oncol Pract (2008) 1.75
Clear cell carcinoma of the ovary: a retrospective multicentre experience of 254 patients with complete surgical staging. Br J Cancer (2006) 1.67
Continued rapid increase in thyroid cancer incidence in california: trends by patient, tumor, and neighborhood characteristics. Cancer Epidemiol Biomarkers Prev (2014) 1.66
MiR-15a and MiR-16 control Bmi-1 expression in ovarian cancer. Cancer Res (2009) 1.64
Reducing racial/ethnic disparities in female breast cancer: screening rates and stage at diagnosis. Am J Public Health (2006) 1.62
Methylated genes in breast cancer: associations with clinical and histopathological features in a familial breast cancer cohort. Cancer Biol Ther (2011) 1.62
The decline in U.S. cancer mortality in people born since 1925. Cancer Res (2009) 1.61
Time to progression of pancreatic ductal adenocarcinoma from low-to-high tumour stages. Gut (2015) 1.59
Underestimation of chronic hepatitis B virus infection in the United States of America. J Viral Hepat (2008) 1.58
Phase II trial of the histone deacetylase inhibitor vorinostat (Zolinza, suberoylanilide hydroxamic acid, SAHA) in patients with recurrent and/or metastatic head and neck cancer. Invest New Drugs (2007) 1.53
Disparities in breast cancer treatment and outcomes: biological, social, and health system determinants and opportunities for research. Oncologist (2013) 1.49
Epidermal growth factor receptor mutations in nonsmall cell lung carcinoma patients in Kuwait. J Cytol (2016) 1.41
The role of cancer registries in cancer control. Int J Clin Oncol (2008) 1.40
Updates on esophageal and gastric cancers. World J Gastroenterol (2006) 1.39
Zoledronic acid prevents bone loss in premenopausal women undergoing adjuvant chemotherapy for early-stage breast cancer. J Clin Oncol (2008) 1.36
A phase II and pharmacodynamic study of gefitinib in patients with refractory or recurrent epithelial ovarian cancer. Cancer (2007) 1.36
Evaluation of record linkage between a large healthcare provider and the Utah Population Database. J Am Med Inform Assoc (2011) 1.35
Socioeconomic disparities in breast cancer survival: relation to stage at diagnosis, treatment and race. BMC Cancer (2009) 1.34
Secular trends in mortality from common cancers in the United States by educational attainment, 1993-2001. J Natl Cancer Inst (2008) 1.34
Synergistic antitumor activity of oncolytic reovirus and chemotherapeutic agents in non-small cell lung cancer cells. Mol Cancer (2009) 1.32
Meat and heterocyclic amine intake, smoking, NAT1 and NAT2 polymorphisms, and colorectal cancer risk in the multiethnic cohort study. Cancer Epidemiol Biomarkers Prev (2009) 1.31
Tumor location and patient characteristics of colon and rectal adenocarcinomas in relation to survival and TNM classes. BMC Cancer (2010) 1.30
Gene therapy for cancer treatment: past, present and future. Clin Med Res (2006) 1.30
The complexities of obesity and diabetes with the development and progression of pancreatic cancer. Biochim Biophys Acta (2010) 1.29
The emerging role of nimotuzumab in the treatment of non-small cell lung cancer. Biologics (2010) 1.26
Bladder cancer in the elderly. Urol Oncol (2009) 1.26
DNA methylation patterns in lung carcinomas. Semin Cancer Biol (2009) 1.25
PET/CT: will it change the way that we use CT in cancer imaging? Cancer Imaging (2006) 1.24
Metformin targets ovarian cancer stem cells in vitro and in vivo. Gynecol Oncol (2012) 1.22
miR-34a and miR-15a/16 are co-regulated in non-small cell lung cancer and control cell cycle progression in a synergistic and Rb-dependent manner. Mol Cancer (2011) 1.19
Molecular analysis of plasma DNA for the early detection of lung cancer by quantitative methylation-specific PCR. Clin Cancer Res (2010) 1.18
Survival disparities by Medicaid status: an analysis of 8 cancers. Cancer (2011) 1.18
Regular adult aspirin use decreases the risk of non-small cell lung cancer among women. Cancer Epidemiol Biomarkers Prev (2008) 1.17
A novel approach to improve health status measurement in observational claims-based studies of cancer treatment and outcomes. J Geriatr Oncol (2013) 1.16
Mitochondrial DNA copy number and pancreatic cancer in the alpha-tocopherol beta-carotene cancer prevention study. Cancer Prev Res (Phila) (2011) 1.16
TGF-β-induced IRAK-M expression in tumor-associated macrophages regulates lung tumor growth. Oncogene (2011) 1.15
Prediagnostic adiponectin concentrations and pancreatic cancer risk in male smokers. Am J Epidemiol (2008) 1.15
Biomonitoring and biomarkers: exposure assessment will never be the same. Environ Health Perspect (2006) 1.15
Gene profiling of canine B-cell lymphoma reveals germinal center and postgerminal center subtypes with different survival times, modeling human DLBCL. Cancer Res (2013) 1.14
Squamous Cell Carcinoma - Similarities and Differences among Anatomical Sites. Am J Cancer Res (2011) 1.13
Thiazolidinediones as anti-cancer agents. Cancer Ther (2008) 1.13
Race versus place of service in mortality among medicare beneficiaries with cancer. Cancer (2010) 1.13
Temporal trends in area socioeconomic disparities in breast-cancer incidence and mortality, 1988-2005. Breast Cancer Res Treat (2010) 1.12
Effects of metastasis-associated in colon cancer 1 inhibition by small hairpin RNA on ovarian carcinoma OVCAR-3 cells. J Exp Clin Cancer Res (2011) 1.12
A randomized controlled trial of hepatectomy with adjuvant transcatheter arterial chemoembolization versus hepatectomy alone for Stage III A hepatocellular carcinoma. J Cancer Res Clin Oncol (2009) 1.12
Breast Cancer Survival Defined by the ER/PR/HER2 Subtypes and a Surrogate Classification according to Tumor Grade and Immunohistochemical Biomarkers. J Cancer Epidemiol (2014) 1.11
Roles and mechanism of miR-199a and miR-125b in tumor angiogenesis. PLoS One (2013) 1.09
Racial/ethnic and socioeconomic disparities in mortality among women diagnosed with cervical cancer in New York City, 1995-2006. Cancer Causes Control (2010) 1.08
AGR2, a mucinous ovarian cancer marker, promotes cell proliferation and migration. Exp Mol Med (2011) 1.08
Tumor-specific and proliferation-specific gene expression typifies murine transgenic B cell lymphomagenesis. J Biol Chem (2006) 1.08
Temporal trends in geographic disparities in small-area breast cancer incidence and mortality, 1988 to 2005. Cancer Epidemiol Biomarkers Prev (2010) 1.06
Overview of cancer stem cells (CSCs) and mechanisms of their regulation: implications for cancer therapy. Curr Protoc Pharmacol (2013) 1.06
Treatment and survival differences in older Medicare patients with lung cancer as compared with those who are dually eligible for Medicare and Medicaid. J Clin Oncol (2008) 1.05
Increased prevalence of testicular microlithiasis in men with familial testicular cancer and their relatives. Br J Cancer (2008) 1.05
Incidence and mortality rates of selected infection-related cancers in Puerto Rico and in the United States. Infect Agent Cancer (2010) 1.04
Cytokine and cytokine receptor single-nucleotide polymorphisms predict risk for non-small cell lung cancer among women. Cancer Epidemiol Biomarkers Prev (2009) 1.02
3,3'-Diindolylmethane induces a G(1) arrest in human prostate cancer cells irrespective of androgen receptor and p53 status. Biochem Pharmacol (2009) 1.02
Enhancing chemotherapy response with Bmi-1 silencing in ovarian cancer. PLoS One (2011) 1.01
Randomized, double-blinded, placebo-controlled crossover trial of treating erectile dysfunction with sildenafil after radiotherapy and short-term androgen deprivation therapy: results of RTOG 0215. J Sex Med (2011) 1.00
Association of chronic diseases and impairments with disability in older adults: a decade of change? Med Care (2012) 1.00
Tumor vasculature targeted photodynamic therapy for enhanced delivery of nanoparticles. ACS Nano (2014) 0.99
Better postdiagnosis diet quality is associated with reduced risk of death among postmenopausal women with invasive breast cancer in the women's health initiative. Cancer Epidemiol Biomarkers Prev (2014) 0.99
Cardiovascular medication use and risk for colorectal cancer. Cancer Epidemiol Biomarkers Prev (2008) 0.99
Who does not receive treatment for cancer? J Oncol Pract (2013) 0.99
Clear cell histology as a poor prognostic factor for advanced epithelial ovarian cancer: a single institutional case series through central pathologic review. J Gynecol Oncol (2013) 0.98
Breast cancer survivorship: a comprehensive review of long-term medical issues and lifestyle recommendations. Perm J (2015) 0.98
Similar reductions in the risk of human colon cancer by selective and nonselective cyclooxygenase-2 (COX-2) inhibitors. BMC Cancer (2008) 0.98
Hypoxia-induced aggressiveness of pancreatic cancer cells is due to increased expression of VEGF, IL-6 and miR-21, which can be attenuated by CDF treatment. PLoS One (2012) 0.98
Clinical and immunological evaluation of anti-apoptosis protein, survivin-derived peptide vaccine in phase I clinical study for patients with advanced or recurrent breast cancer. J Transl Med (2008) 0.98
Conditionally replicating adenoviruses for cancer treatment. Curr Cancer Drug Targets (2007) 0.98
Global cancer statistics. CA Cancer J Clin (2011) 185.92
Cancer statistics, 2010. CA Cancer J Clin (2010) 103.28
Cancer statistics, 2012. CA Cancer J Clin (2012) 87.38
Cancer statistics, 2008. CA Cancer J Clin (2008) 86.74
Cancer statistics, 2013. CA Cancer J Clin (2013) 84.72
Cancer statistics, 2009. CA Cancer J Clin (2009) 83.57
Cancer statistics, 2014. CA Cancer J Clin (2014) 72.81
Cancer statistics, 2015. CA Cancer J Clin (2015) 57.51
Global cancer statistics, 2012. CA Cancer J Clin (2015) 53.52
Cancer statistics, 2007. CA Cancer J Clin (2007) 53.49
Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin (2011) 30.81
Cancer statistics, 2006. CA Cancer J Clin (2006) 30.71
Cancer statistics, 2005. CA Cancer J Clin (2005) 25.65
Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population. Med Care (2002) 21.63
Cancer statistics, 2004. CA Cancer J Clin (2004) 15.72
Cancer treatment and survivorship statistics, 2012. CA Cancer J Clin (2012) 14.47
Cancer statistics, 2003. CA Cancer J Clin (2003) 13.46
Colorectal cancer statistics, 2014. CA Cancer J Clin (2014) 12.86
Cancer disparities by race/ethnicity and socioeconomic status. CA Cancer J Clin (2004) 12.55
Primary care physicians who treat blacks and whites. N Engl J Med (2004) 12.23
Cancer treatment and survivorship statistics, 2014. CA Cancer J Clin (2014) 11.09
Patients' expectations about effects of chemotherapy for advanced cancer. N Engl J Med (2012) 10.93
Projections of the cost of cancer care in the United States: 2010-2020. J Natl Cancer Inst (2011) 10.29
Annual report to the nation on the status of cancer, 1975-2001, with a special feature regarding survival. Cancer (2004) 9.24
Annual Report to the Nation on the Status of Cancer, 1975-2009, featuring the burden and trends in human papillomavirus(HPV)-associated cancers and HPV vaccination coverage levels. J Natl Cancer Inst (2013) 8.75
Trends in the leading causes of death in the United States, 1970-2002. JAMA (2005) 8.20
Annual report to the nation on the status of cancer, 1975-2005, featuring trends in lung cancer, tobacco use, and tobacco control. J Natl Cancer Inst (2008) 8.14
Cetuximab shows activity in colorectal cancer patients with tumors that do not express the epidermal growth factor receptor by immunohistochemistry. J Clin Oncol (2005) 8.08
International variation in prostate cancer incidence and mortality rates. Eur Urol (2012) 8.04
Cost of care for elderly cancer patients in the United States. J Natl Cancer Inst (2008) 7.85
21st-century hazards of smoking and benefits of cessation in the United States. N Engl J Med (2013) 7.77
Breast cancer statistics, 2013. CA Cancer J Clin (2013) 7.35
Variations in morbidity after radical prostatectomy. N Engl J Med (2002) 7.26
American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer. J Clin Oncol (2004) 7.16
Annual report to the nation on the status of cancer, 1975-2000, featuring the uses of surveillance data for cancer prevention and control. J Natl Cancer Inst (2003) 7.06
Annual report to the nation on the status of cancer, 1975-2004, featuring cancer in American Indians and Alaska Natives. Cancer (2007) 6.84
American Society of Clinical Oncology guidance statement: the cost of cancer care. J Clin Oncol (2009) 6.77
Care patterns in Medicare and their implications for pay for performance. N Engl J Med (2007) 6.74
Racial and ethnic disparities in the receipt of cancer treatment. J Natl Cancer Inst (2002) 6.64
Global cancer transitions according to the Human Development Index (2008-2030): a population-based study. Lancet Oncol (2012) 6.37
Breast cancer statistics, 2011. CA Cancer J Clin (2011) 6.12
The surgical learning curve for prostate cancer control after radical prostatectomy. J Natl Cancer Inst (2007) 6.12
Annual report to the nation on the status of cancer, 1973-1999, featuring implications of age and aging on U.S. cancer burden. Cancer (2002) 6.08
Cancer incidence, mortality, and associated risk factors among Asian Americans of Chinese, Filipino, Vietnamese, Korean, and Japanese ethnicities. CA Cancer J Clin (2007) 5.67
Using navigators to improve care of underserved patients: current practices and approaches. Cancer (2005) 5.56
Increasing incidence of differentiated thyroid cancer in the United States, 1988-2005. Cancer (2009) 5.55
Use of natural language processing to translate clinical information from a database of 889,921 chest radiographic reports. Radiology (2002) 5.52
Resurrecting treatment histories of dead patients: a study design that should be laid to rest. JAMA (2004) 5.43
Association of insurance with cancer care utilization and outcomes. CA Cancer J Clin (2007) 5.31
Gemcitabine plus bevacizumab compared with gemcitabine plus placebo in patients with advanced pancreatic cancer: phase III trial of the Cancer and Leukemia Group B (CALGB 80303). J Clin Oncol (2010) 5.21
Deaths: leading causes for 2000. Natl Vital Stat Rep (2002) 5.16
Outcomes for children and adolescents with cancer: challenges for the twenty-first century. J Clin Oncol (2010) 5.11
Annual report to the nation on the status of cancer, 1975-2007, featuring tumors of the brain and other nervous system. J Natl Cancer Inst (2011) 5.09
Adverse symptom event reporting by patients vs clinicians: relationships with clinical outcomes. J Natl Cancer Inst (2009) 5.05
Oral contraceptives and the risk of breast cancer. N Engl J Med (2002) 4.85
A refined comorbidity measurement algorithm for claims-based studies of breast, prostate, colorectal, and lung cancer patients. Ann Epidemiol (2007) 4.81
Cancer mortality in the United States by education level and race. J Natl Cancer Inst (2007) 4.77
Trends in breast cancer by race and ethnicity: update 2006. CA Cancer J Clin (2006) 4.73
Annual report to the nation on the status of cancer, 1975-2003, featuring cancer among U.S. Hispanic/Latino populations. Cancer (2006) 4.71
Worldwide variations in colorectal cancer. CA Cancer J Clin (2009) 4.71
Cancer incidence and mortality patterns among specific Asian and Pacific Islander populations in the U.S. Cancer Causes Control (2007) 4.61